Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapo...

por Nehls, O, Okech, T, Hsieh, C-J, Enzinger, T, Sarbia, M, Borchard, F, Gruenagel, H-H, Gaco, V, Hass, H G, Arkenau, H T, Hartmann, J T, Porschen, R, Gregor, M, Klump, B
Publicado 2007

The hollow fibre assay as a model for in vivo pharmacodynamics of fluoropyrimidines in colon cancer cells

por Temmink, O H, Prins, H-J, van Gelderop, E, Peters, G J
Publicado 2007

Capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours: results of an extended phase-I trial

por Ernst, T, Merx, K, Gnad-Vogt, U, Lukan, N, Kripp, M, Schultheis, B, Hochhaus, A, Hofheinz, R-D
Publicado 2007

Photochemical internalisation of chemotherapy potentiates killing of multidrug-resistant breast and bladder cancer cells

por Adigbli, D K, Wilson, D G G, Farooqui, N, Sousi, E, Risley, P, Taylor, I, MacRobert, A J, Loizidou, M
Publicado 2007

NF-κB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation

por Van Laere, S J, Van der Auwera, I, Van den Eynden, G G, van Dam, P, Van Marck, E A, Vermeulen, P B, Dirix, L Y
Publicado 2007

Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications

por Gakiopoulou, H, Korkolopoulou, P, Levidou, G, Thymara, I, Saetta, A, Piperi, C, Givalos, N, Vassilopoulos, I, Ventouri, K, Tsenga, A, Bamias, A, Dimopoulos, M-A, Agapitos, E, Patsouris, E
Publicado 2007

High incidence of silent venous thromboembolism before treatment in ovarian cancer

por Satoh, T, Oki, A, Uno, K, Sakurai, M, Ochi, H, Okada, S, Minami, R, Matsumoto, K, Tanaka, Y O, Tsunoda, H, Homma, S, Yoshikawa, H
Publicado 2007

Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1

por de Groot, D J A, van der Deen, M, Le, T K P, Regeling, A, de Jong, S, de Vries, E G E
Publicado 2007

Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma

por Amant, F, De Knijf, A, Van Calster, B, Leunen, K, Neven, P, Berteloot, P, Vergote, I, Van Huffel, S, Moerman, P
Publicado 2007

Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer

por Leitch, E F, Chakrabarti, M, Crozier, J E M, McKee, R F, Anderson, J H, Horgan, P G, McMillan, D C
Publicado 2007

Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linke...

por Cummings, J, Ranson, M, LaCasse, E, Ganganagari, J R, St-Jean, M, Jayson, G, Durkin, J, Dive, C
Publicado 2006

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer

por Griebsch, I, Brown, J, Boggis, C, Dixon, A, Dixon, M, Easton, D, Eeles, R, Evans, D G, Gilbert, F J, Hawnaur, J, Kessar, P, Lakhani, S R, Moss, S M, Nerurkar, A, Padhani, A R, Pointon, L J, Potterton, J, Thompson, D, Turnbull, L W, Walker, L G, Warren, R, Leach, M O
Publicado 2006

Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer

por von Plessen, C, Bergman, B, Andresen, O, Bremnes, R M, Sundstrom, S, Gilleryd, M, Stephens, R, Vilsvik, J, Aasebo, U, Sorenson, S
Publicado 2006

SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel–gemcitabine as first-line chemotherapy for ovarian cancer

por Vasey, P A, Atkinson, R, Osborne, R, Parkin, D, Symonds, R, Paul, J, Lewsley, L, Coleman, R, Reed, N S, Kaye, S, Rustin, G J S
Publicado 2006

A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen

por Culine, S, Theodore, C, De Santis, M, Bui, B, Demkow, T, Lorenz, J, Rolland, F, Delgado, F-M, Longerey, B, James, N
Publicado 2006

Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis

por Pearce, C L, Wu, A H, Gayther, S A, Bale, A E, Beck, P A, Beesley, J, Chanock, S, Cramer, D W, DiCioccio, R, Edwards, R, Fredericksen, Z S, Garcia-Closas, M, Goode, E L, Green, A C, Hartmann, L C, Hogdall, E, Kjær, S K, Lissowska, J, McGuire, V, Modugno, F, Moysich, K, Ness, R B, Ramus, S J, Risch, H A, Sellers, T A, Song, H, Stram, D O, Terry, K L, Webb, P M, Whiteman, D C, Whittemore, A S, Zheng, W, Pharoah, P D P, Chenevix-Trench, G, Pike, M C, Schildkraut, J, Berchuck, A
Publicado 2008

Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer

por Lin, H-J, Hsieh, F-C, Song, H, Lin, J
Publicado 2005

Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures

por Apolone, G, Joppi, R, Bertele', V, Garattini, S
Publicado 2005

Array comparative genomic hybridisation (aCGH) analysis of premenopausal breast cancers from a nuclear fallout area and matched cases from Western New York

por Varma, G, Varma, R, Huang, H, Pryshchepava, A, Groth, J, Fleming, D, Nowak, N J, McQuaid, D, Conroy, J, Mahoney, M, Moysich, K, Falkner, K L, Geradts, J
Publicado 2005

An immunohistochemical perspective of PPARβ and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours

por Ahmed, N, Riley, C, Quinn, M A
Publicado 2008